Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery
1 other identifier
observational
1,000
2 countries
16
Brief Summary
Little is known about pain-related outcomes experienced by patients in the first few weeks after surgery, once they are discharged from hospital. This study aims to characterize pain, pain-related interference, and early neuropathic pain in the sub-acute phase after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Longer than P75 for all trials
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 23, 2022
CompletedFirst Posted
Study publicly available on registry
April 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
April 7, 2022
March 1, 2022
8.9 years
February 23, 2022
March 29, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
The difference in pain interference scores between postoperative day 7 (POD7) and 1 month after surgery (POM1).
We will assess whether pain-related functional impairment on postoperative day 7 is associated with functional pain-related impairment 1 month after surgery. Functional pain impairment will be assessed using the BPI short-form questionnaire and calculated as a Pain Interference Total Score (PITS) from the 7 interference questions in the BPI. Patients will be allocated to groups of no (PITS=0)/mild-(PITS=1-2)/ moderate /(PITS=2-5) and severe interference (PITS\>5). Mean scores of the 2 domains within the functional items, physical interference (general activity, walking ability, and work) and effective interference (mood, enjoyment of life, and relations with other persons) will also be calculated. Sleep will addressed separately as it does not improve psychometric properties of the BPI interference scale. This methodology has been used in another PAIN OUT study, evaluating function at 6 months after surgery (Stamer et al, Pain. 2019 Aug;160(8):1856-1865).
7th day after surgery (POD7) and 1 Month (M1) after surgery
The number of patients with high pain interference on the 7th day after surgery (POD7).
Number of patients with high pain interference at postoperative day 7 (POD7, BPI-PITS \>5).
Day 7 after surgery
Secondary Outcomes (9)
Differences in pain severity (BPI-PSVS, pain severity scale) between postoperative day 7 and 1 month after surgery (POM1).
Day 7 after surgery and Month 1 after surgery
The differences in pain interference (BPI-PITS) between surgical disciplines on postoperative day 7.
Day 7 after surgery
The differences in pain interference (BPI-PITS) between surgical disciplines at month 1 after surgery.
1 Month after surgery
The difference in the number of patients with signs of neuropathy on postoperative day 7 between the surgical disciplines.
Day 7 after surgery
The difference in the number of patients with signs of neuropathy at 1 month after surgery (POM1) between the surgical disciplines.
1 Month after surgery
- +4 more secondary outcomes
Other Outcomes (3)
Exploratory regression analysis for improving understanding of pain interference on day 7 after surgery
First postoperative day and postoperative day 7
Exploratory regression analysis for improving understanding of pain intensity on postoperative day 7.
First postoperative day and postoperative day 7
Exploratory regression analysis for improving understanding of pain intensity at POM1
First postoperative day and 1 month after surgery
Eligibility Criteria
Adult patients after surgery
You may qualify if:
- Adult
- On the first post-operative day and back on the ward for at least 6 hours
- Gives consent for assessment at 3-time points
You may not qualify if:
- The patient is unable to communicate
- The patient is cognitively impaired
- The patient is asleep
- The patient is too ill or in too much pain and does not wish to be interviewed
- The patient does not wish to fill in the outcomes questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jena University Hospitallead
- Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubiráncollaborator
- Centro Medico Nacional Siglo XXI IMSScollaborator
- Hospital de Traumatología y Ortopedia Lomas Verdescollaborator
- Hospital Angeles Pueblacollaborator
- Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondocollaborator
- Hospital Angeles Lomascollaborator
- Hospital San Javier Guadalajaracollaborator
- Hospital Aranda de La Parra (Leon Guanajuato)collaborator
- Fundación Clínica Médica Surcollaborator
- Instituto Nacional de Cancerologia de Mexicocollaborator
- Hospital General Dr. Ruben Leñerocollaborator
- Hospital Central "Dr. Ignacio Morones Prieto"collaborator
- Hospital General Regional Número 2 Dr. Guillermo Fajardo Ortizcollaborator
- Instituto Nacional de Enfermedades Respiratoriascollaborator
- Hospital Central Militarcollaborator
Study Sites (16)
Jena University Hospital
Jena, Germany
Hospital General de Chihuahua Salvador Zubirán Anchondo
El Bajo, Chihuahua, Mexico
Hospital Aranda de La Parra (Leon Guanajuato)
León, Guanajuato, Mexico
Hospital Central Militar
Mexico City, Mexico City, Mexico
Hospital San Javier Guadalajara
Guadalajara, Mexico
Centro Nacional SIGLO XXI (IMSS)
Mexico City, Mexico
Hospital Angeles Interlomas CDMX
Mexico City, Mexico
Hospital de traumatologia y Ortopedia Lomas Verdes (IMSS)
Mexico City, Mexico
Hospital fundación Medica Sur
Mexico City, Mexico
Hospital General de Villacoapa (IMSS)
Mexico City, Mexico
Hospital Ruben Leñero
Mexico City, Mexico
Instituto Nacional de Cancerología
Mexico City, Mexico
Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán
Mexico City, Mexico
Instituto Nacional de Enfermedades Respiratorias Cosio Villegas (INER)
Mexico City, Mexico
Hospital Angeles Puebla
Puebla City, Mexico
Hospital Central Morones Prieto San Luis Potosi
San Luis Potosí City, Mexico
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ana L Garduño López, MD
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- PRINCIPAL INVESTIGATOR
Vicotor M Acosta-Nava, MD
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- PRINCIPAL INVESTIGATOR
Ruth Zaslansky, DSc
Jena University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PAIN OUT - scientific director
Study Record Dates
First Submitted
February 23, 2022
First Posted
April 7, 2022
Study Start
February 1, 2022
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
April 7, 2022
Record last verified: 2022-03